Omeros Corporation ( OMER) - Stock Earnings
OMER Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
OMER Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -30.9 million USD | — USD |
| 2025Q4 | 86.5 million USD | — USD |
| 2026Q1 | 56.1 million USD | 9.9 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
OMER Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -117.8 million USD | — USD |
| 2024 | -156.8 million USD | — USD |
| 2025 | -3.4 million USD | — USD |
| 2026 Est. | — | — |
OMER
Price: $9.79
Earnings Per Share: 1.14 USD
P/E Ratio: 10.26
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 328300
Ebitda: -4.6 millionMarket Capitalization: 671.6 million